Cargando…
A review of the methods used to define glucocorticoid exposure and risk attribution when investigating the risk of fracture in a rheumatoid arthritis population
BACKGROUND: Glucocorticoid therapy is used widely in patients with rheumatoid arthritis (RA) with good efficacy but concerns about safety including fractures. Estimates of fracture risk for any given patient are complicated by the dynamic pattern of glucocorticoid use, where patients vary in their d...
Autores principales: | Robinson, D.E., Dennison, E.M., Cooper, C., van Staa, T.P., Dixon, W.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973893/ https://www.ncbi.nlm.nih.gov/pubmed/27268854 http://dx.doi.org/10.1016/j.bone.2016.06.001 |
Ejemplares similares
-
The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: A cohort study
por: Robinson, Danielle E., et al.
Publicado: (2018) -
Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
por: Riley, Thomas R, et al.
Publicado: (2021) -
Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink
por: Abtahi, Shahab, et al.
Publicado: (2021) -
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
por: Dixon, William G, et al.
Publicado: (2011) -
Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis
por: Kavanaugh, Arthur, et al.
Publicado: (2014)